AP-1 Genes Drive Lung Allograft Dysfunction 02/10/26

Welcome to Cardiology Today – Recorded February 10, 2026. This episode summarizes 5 key cardiology studies on topics like endothelium and cost-utility analysis. Key takeaway: AP-1 Genes Drive Lung Allograft Dysfunction. Article Links: Article 1: Incidence, Risk Factors, and Outcomes in Stressor-Associated Atrial Fibrillation: Insights From the VITAL-AF Trial. (Circulation) Article 2: Spatial transcriptomics reveals coordinated endothelial and epithelial activator protein-1 activation in CLAD. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 3: Economic evaluation of ex-vivo lung perfusion for lung transplantation: a cost-utility analysis from a large Canadian centre. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 4: Bone Benefits After Simultaneous Pancreas-kidney Transplantation Compared With the Pretransplant Period. (Transplantation) Article 5: Association between body mass index, plasma N-terminal pro-B-type natriuretic peptide, symptoms and outcome in patients referred for investigation of suspected heart failure. (Heart (British Cardiac Society)) Full episode page: https://podcast.explainheart.com/podcast/ap-1-genes-drive-lung-allograft-dysfunction-02-10-26/ Featured Articles Article 1: Incidence, Risk Factors, and Outcomes in Stressor-Associated Atrial Fibrillation: Insights From the VITAL-AF Trial. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41662456 Summary: This study found that stressor-associated atrial fibrillation, defined as newly diagnosed atrial fibrillation in the presence of a reversible physiological stressor, is a common clinical entity. The VITAL-AF trial characterized this patient population, which comprised adults aged 65 years and older across primary care practices. This research highlights the widespread occurrence of this specific atrial fibrillation subtype, underscoring its clinical significance for diagnosis and management. The findings establish the importance of distinguishing stressor-associated atrial fibrillation for improved risk stratification in older adults. Article 2: Spatial transcriptomics reveals coordinated endothelial and epithelial activator protein-1 activation in CLAD. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41663041 Summary: Spatial transcriptomic analyses of human lungs with chronic lung allograft dysfunction revealed significant upregulation of activator protein-1 target genes, including JUNB and FOS. This upregulation was observed in both the epithelial and endothelial tissues of patients with chronic lung allograft dysfunction. The data demonstrated coordinated activator protein-1 activation in these cell types within affected lung allografts. This provides novel insight into the disease pathology of chronic lung allograft dysfunction. Article 3: Economic evaluation of ex-vivo lung perfusion for lung transplantation: a cost-utility analysis from a large Canadian centre. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41663040 Summary: Ex-vivo lung perfusion enables the evaluation and rehabilitation of potentially usable donor lungs outside the body prior to transplantation. This study established a comprehensive cost-utility analysis model for integrating ex-vivo lung perfusion into lung transplant programs, adopting a hospital perspective. The model utilizes individual-level simulation over a lifetime horizon for adults with end-stage lung disease awaiting transplantation. This research provides a critical tool for assessing the health economic implications of technologies that expand the donor organ pool and improve transplant outcomes. Article 4: Bone Benefits After Simultaneous Pancreas-kidney Transplantation Compared With the Pretransplant Period. Journal: Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41656551 Summary: Bone health is frequently compromised in patients with type one diabetes and advanced diabetic kidney disease. This study characterized changes in bone mineral density and trabecular bone score before and after simultaneous pancreas-kidney transplantation in 48 patients. This research addresses the critical skeletal impact of simultaneous pancreas-kidney transplantation in this vulnerable patient population. It highlights the importance of understanding bone changes in the context of immunosuppressive regimens. Article 5: Association between body mass index, plasma N-terminal pro-B-type natriuretic peptide, symptoms and outcome in patients referred for investigation of suspected heart failure. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41663268 Summary: Obesity is associated with lower N-terminal pro-B-type natriuretic peptide concentrations, and obese patients often present with heart failure symptoms at less severe levels of left ventricular dysfunction. This study characterized the complex interrelationship among body mass index, left ventricular ejection fraction, heart failure symptoms, N-terminal pro-B-type natriuretic peptide levels, and mortality. The research highlights the critical need to consider body mass index when interpreting N-terminal pro-B-type natriuretic peptide levels. It identifies specific factors influencing symptom presentation and mortality risk in individuals with suspected heart failure. Transcript Today’s date is February 10, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Incidence, Risk Factors, and Outcomes in Stressor-Associated Atrial Fibrillation: Insights From the VITAL-AF Trial. This study found that stressor-associated atrial fibrillation, defined as newly diagnosed atrial fibrillation in the presence of a reversible physiological stressor, is a common clinical entity. The VITAL-AF trial characterized this patient population, which comprised adults aged 65 years and older across primary care practices. This research highlights the widespread occurrence of this specific atrial fibrillation subtype, underscoring its clinical significance for diagnosis and management. The findings establish the importance of distinguishing stressor-associated atrial fibrillation for improved risk stratification in older adults. Article number two. Spatial transcriptomics reveals coordinated endothelial and epithelial activator protein-1 activation in CLAD. Spatial transcriptomic analyses of human lungs with chronic lung allograft dysfunction revealed significant upregulation of activator protein-1 target genes, including JUNB and FOS. This upregulation was observed in both the epithelial and endothelial tissues of patients with chronic lung allograft dysfunction. The data demonstrated coordinated activator protein-1 activation in these cell types within affected lung allografts. This provides novel insight into the disease pathology of chronic lung allograft dysfunction. Article number three. Economic evaluation of ex-vivo lung perfusion for lung transplantation: a cost-utility analysis from a large Canadian centre. Ex-vivo lung perfusion enables the evaluation and rehabilitation of potentially usable donor lungs outside the body prior to transplantation. This study established a comprehensive cost-utility analysis model for integrating ex-vivo lung perfusion into lung transplant programs, adopting a hospital perspective. The model utilizes individual-level simulation over a lifetime horizon for adults with end-stage lung disease awaiting transplantation. This research provides a critical tool for assessing the health economic implications of technologies that expand the donor organ pool and improve transplant outcomes. Article number four. Bone Benefits After Simultaneous Pancreas-kidney Transplantation Compared With the Pretransplant Period. Bone health is frequently compromised in patients with type one diabetes and advanced diabetic kidney disease. This study characterized changes in bone mineral density and trabecular bone score before and after simultaneous pancreas-kidney transplantation in 48 patients. This research addresses the critical skeletal impact of simultaneous pancreas-kidney transplantation in this vulnerable patient population. It highlights the importance of understanding bone changes in the context of immunosuppressive regimens. Article number five. Association between body mass index, plasma N-terminal pro-B-type natriuretic peptide, symptoms and outcome in patients referred for investigation of suspected heart failure. Obesity is associated with lower N-terminal pro-B-type natriuretic peptide concentrations, and obese patients often present with heart failure symptoms at less severe levels of left ventricular dysfunction. This study characterized the complex interrelationship among body mass index, left ventricular ejection fraction, heart failure symptoms, N-terminal pro-B-type natriuretic peptide levels, and mortality. The research highlights the critical need to consider body mass index when interpreting N-terminal pro-B-type natriuretic peptide levels. It identifies specific factors influencing symptom presentation and mortality risk in individuals with suspected heart failure. Thank you for listening. Don’t forget to subscribe. Keywords endothelium, cost-utility analysis, donor lungs, atrial fibrillation, spatial transcriptomics, health economics, primary care, type one diabetes, VITAL-AF trial, N-terminal pro-B-type natriuretic peptide, bone mineral density, immunosuppression, stressor-associated, diabetic kidney disease, mortality, lung transplantation, activator protein-1, epithelium, older adults, chronic lung allograft dysfunction, left ventricular ejection fraction, ex-vivo lung perfusion, body mass index, heart failure, simultaneous pancreas-kidney transplantation. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post AP-1 Genes Drive Lung Allograft Dysfunction 02/10/26 first appeared on Cardiology Today.